作者: Marimuthu Mohana , Packianathan Thomas Muthiah , Colin D. McMillen
DOI: 10.1107/S2053229617001486
关键词:
摘要: The design of a pharmaceutical cocrystal is based on the identification specific hydrogen-bond donor and acceptor groups in active ingredients (APIs) order to choose `complementary interacting' molecule that can act as an efficient coformer. 5-Fluorouracil (5FU) pyrimidine derivative with two N—H donors C=O acceptors shows diversity hydrogen-bonding motifs. Two 1:1 cocrystals 5-fluorouracil (5FU), namely 5-fluorouracil–4-methylbenzoic acid (5FU–MBA), C4H3FN2O2·C8H8O2, (I), 5-fluorouracil–3-nitrobenzoic (5FU–NBA), C4H3FN2O2·C7H5NO4, (II), have been prepared characterized by single-crystal X-ray diffraction. In MBA molecules form carboxylic dimers [R22(8) homosynthon]. Similarly, 5FU types base pair via N—H⋯O hydrogen bonds interacts group NBA O—H⋯O bonds, generating R22(8) ring motif (heterosynthon). Furthermore, pairs homosynthon] bonds. Both crystal structures are stabilized C—H⋯F interactions.